NCT05864144 2025-08-15
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Sensei Biotherapeutics, Inc.
Phase 1/2 Active not recruiting
Sensei Biotherapeutics, Inc.
University Medical Center Groningen
Columbia University
HotSpot Therapeutics, Inc
Peter MacCallum Cancer Centre, Australia
SillaJen, Inc.